
About Ctga Biopharma India Private Limited
Data last updated:
Ctga Biopharma India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U15549TG2017PTC116484. Its GSTIN is 36AAGCC9480R1ZQ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ashok Mandava and Mandava Nagalatha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.77 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹83,458 (net margin 1.8%) and EBITDA of ₹12.99 Lakh (EBITDA margin 28.4%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 28% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ctgabiopharma.com.
Company details
Contact details
Ctga Biopharma India Private Limited's registered office is in Hyderabad, Telangana. Its website is ctgabiopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS.Y No 122/Aa, Thukkuguda Maheshwaram, Hyderabad, Telangana, India – 501359
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ctga Biopharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ctga Biopharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ctga Biopharma India Private Limited, buy the company report.
Financials of Ctga Biopharma India Private Limited
FY 2025 filings availableCtga Biopharma India Private Limited reported revenue of ₹45.77 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 28% over five years, including a 11% fall in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83,458 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ctga Biopharma India Private Limited, buy the company report.
Board of directors of Ctga Biopharma India Private Limited
Ctga Biopharma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Mandava Also directs: VN Poultry Products Private Limited, VN Hatcheries Private Limited, Terra Deccan Developers India Private Limited and 1 more | Director | 11 Apr 2017 | 9 Years 7 Months | Current |
| Mandava Nagalatha Also directs: VN Poultry Products Private Limited, VN Hatcheries Private Limited | Director | 11 Apr 2017 | 9 Years 7 Months | Current |
Peer comparison
Ctga Biopharma India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gloled Pharma Pvt Ltd | ₹46.06 Lakh (FY 2025) | -11.0% | Haryana, India | |||
| Curemart Pharma Private Limited | ₹45.79 Lakh (FY 2024) | 2066.0% | New Delhi, Delhi, India | |||
| Ctga Biopharma India Private Limitedthis company | ₹45.77 Lakh (FY 2025) | ₹83,458 | 1.8% | -11.0% | Hyderabad, Telangana, India | |
| Lograns Pharma Private Limited | ₹45.53 Lakh (FY 2025) | 14.0% | Hyderabad, Telangana, India | |||
| Lepidus Pharma India Private Limited | ₹45.31 Lakh (FY 2016) | Hyderabad, Telangana, India |
To see the full peer comparison of Ctga Biopharma India Private Limited, buy the company report.
Auditor
Ctga Biopharma India Private Limited is audited by MAHENDER & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAHENDER & CO | FY 2019 | 012854S |
Shareholding
The shareholding of Ctga Biopharma India Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ctga Biopharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ctga Biopharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ctga Biopharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ctga Biopharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC9480R1ZQ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ctga Biopharma India Private Limited, buy the company report.
Recent activity
Ctga Biopharma India Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Subrata Misra ceased to be Managing Director on 13 Jan 2021.
Frequently asked questions
Ctga Biopharma India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 April 2017 (9+ years old) and is registered under CIN U15549TG2017PTC116484.
Ctga Biopharma India has 2 current directors:
- Ashok Mandava - Director
- Mandava Nagalatha - Director
The latest financial statements of Ctga Biopharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ctga Biopharma India is 36AAGCC9480R1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Ctga Biopharma India is U15549TG2017PTC116484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ctga Biopharma India was incorporated on 11 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ctga Biopharma India by revenue are Gloled Pharma Pvt Ltd, Curemart Pharma Private Limited, Lograns Pharma Private Limited, Lepidus Pharma India Private Limited, all in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Subrata Misra ceased to be Managing Director on 13 Jan 2021. Ashok Mandava was appointed as Director on 11 Apr 2017. Mandava Nagalatha was appointed as Director on 11 Apr 2017.
Ctga Biopharma India can be reached through the website ctgabiopharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Ctga Biopharma India is at S.Y No 122Aa, Thukkuguda Maheshwaram, Hyderabad, Telangana, India – 501359.
Ctga Biopharma India operates in the pharma industry, in the drug formulation and development segment.

